Issued Patents All Time
Showing 1–25 of 32 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12383617 | Compositions and methods concerning immune tolerance | Jeffrey A. Hubbell, Kym Brünggel, Kristen Marie Lorentz | 2025-08-12 |
| 12281148 | Anti-pd-1 antibody-attenuated IL-2 immunoconjugates and uses thereof | Kim Tran YAP, Paul Ayton, Debasish SEN, Julia ROZENFELD, Sachin Surade +1 more | 2025-04-22 |
| 11801305 | Glycotargeting therapeutics | Jeffrey A. Hubbell | 2023-10-31 |
| 11793882 | Glycotargeting therapeutics | Jeffrey A. Hubbell | 2023-10-24 |
| 11707526 | Polymer hydrogels for in vivo applications and methods for using and preparing same | Niren Murthy, Christopher D. Hermann, Xinghai Ning, Barbara D. Boyan, Zvi Schwartz +2 more | 2023-07-25 |
| 11666638 | Glycotargeting therapeutics | Jeffrey A. Hubbell, Stephane Kontos, Kristen Marie Lorentz, Shuning Gai | 2023-06-06 |
| 11654188 | Glycotargeting therapeutics | Jeffrey A. Hubbell, Stephane Kontos, Kristen Marie Lorentz, Shuning Gai | 2023-05-23 |
| 11542339 | Anti-CD43 antibody and use thereof for cancer treatment | Kwon Hong, Sangsoon Yoon, Irene Koukoulas, Vincent Batori, Briony Cristiano +1 more | 2023-01-03 |
| 11484599 | Polymer conjugate vaccines | Jeffrey A. Hubbell, Sachiko Hirosue | 2022-11-01 |
| 11253597 | Polymer hydrogels for in vivo applications and methods for using and preparing same | Niren Murthy, Christopher D. Hermann, Xinghai Ning, Barbara D. Boyan, Zvi Schwartz +2 more | 2022-02-22 |
| 11253591 | Combination of lenalidomide and polypeptide construct, and uses thereof | Sarah L. Pogue, Anthony G. Doyle, Collette Behrens | 2022-02-22 |
| 11253579 | Compositions and methods for inducing immune tolerance | Jeffrey A. Hubbell, Kristen Marie Lorentz, Stephan Kontos | 2022-02-22 |
| 11117975 | Anti-CD38 antibodies and fusions to attenuated interferon alpha-2B | Adam Clarke, Matthew Pollard, Anthony G. Doyle, Collette Behrens, Tetsuo Yamagishi +2 more | 2021-09-14 |
| 10981986 | Fusions of antibodies to CD38 and attenuated interferon alpha | Sarah L. Pogue, Glen Eugene Mikesell, Tetsuya Taura, Wouter Korver, Anthony G. Doyle +4 more | 2021-04-20 |
| 10953101 | Glycotargeting therapeutics | Jeffrey A. Hubbell | 2021-03-23 |
| 10946079 | Glycotargeting therapeutics | Jeffrey A. Hubbell | 2021-03-16 |
| 10940209 | Glycotargeting therapeutics | Jeffrey A. Hubbell | 2021-03-09 |
| 10906973 | Antibody variants transmigrating the blood-brain barrier and uses thereof | Danica Stanimirovic, Traian Sulea, Kristin Kemmerich, Jennifer Stratton, Matthew Pollard +1 more | 2021-02-02 |
| 10821157 | Glycotargeting therapeutics | Jeffrey A. Hubbell, Stephane Kontos, Kristen Marie Lorentz, Shuning Gai | 2020-11-03 |
| 10676531 | Anti-CD43 antibody and use thereof for cancer treatment | Kwon Hong, Sangsoon Yoon, Irene Koukoulas, Vincent Batori, Briony Cristiano +1 more | 2020-06-09 |
| 10232041 | Combination of lenalidomide and polypeptide construct, and uses thereof | Sarah L. Pogue, Anthony G. Doyle, Collette Behrens | 2019-03-19 |
| 10183020 | Pharmaceutical compositions comprising AZD9291 | Cindy FINNIE, Steven Anthony RAW | 2019-01-22 |
| 10046056 | Glycotargeting therapeutics | Jeffrey A. Hubbell | 2018-08-14 |
| 10039831 | Polymer hydrogels for in vivo applications and methods for using and preparing same | Niren Murthy, Christopher D. Hermann, Xinghai Ning, Barbara D. Boyan, Zvi Schwartz +2 more | 2018-08-07 |
| 9963515 | Anti-CD38 antibodies and fusions to attenuated interferon alpha-2B | Adam Clarke, Matthew Pollard, Anthony G. Doyle, Collette Behrens, Tetsuo Yamagishi +2 more | 2018-05-08 |